361 related articles for article (PubMed ID: 17185787)
1. Insulin resistance in PCOS.
Diamanti-Kandarakis E
Endocrine; 2006 Aug; 30(1):13-7. PubMed ID: 17185787
[TBL] [Abstract][Full Text] [Related]
2. Insulin and hyperandrogenism in women with polycystic ovary syndrome.
Baptiste CG; Battista MC; Trottier A; Baillargeon JP
J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):42-52. PubMed ID: 20036327
[TBL] [Abstract][Full Text] [Related]
3. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
González F
Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
[TBL] [Abstract][Full Text] [Related]
4. PCOS in adolescence and type 2 diabetes.
Carreau AM; Baillargeon JP
Curr Diab Rep; 2015 Jan; 15(1):564. PubMed ID: 25398203
[TBL] [Abstract][Full Text] [Related]
5. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
[TBL] [Abstract][Full Text] [Related]
7. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms.
Dumitrescu R; Mehedintu C; Briceag I; Purcarea VL; Hudita D
J Med Life; 2015; 8(2):142-5. PubMed ID: 25866568
[TBL] [Abstract][Full Text] [Related]
8. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
Legro RS; Castracane VD; Kauffman RP
Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
Dunaif A
Endocr Rev; 1997 Dec; 18(6):774-800. PubMed ID: 9408743
[TBL] [Abstract][Full Text] [Related]
10. Massive Ovarian Growth in a Woman With Severe Insulin-Resistant Polycystic Ovary Syndrome Receiving GnRH Analogue.
Singh P; Agress A; Madrigal VK; Magyar C; Ostrzega N; Chazenbalk GD; Dumesic DA
J Clin Endocrinol Metab; 2019 Jul; 104(7):2796-2800. PubMed ID: 30759233
[TBL] [Abstract][Full Text] [Related]
11. The role of insulin and selected adipocytokines in patients with polycystic ovary syndrome (PCOS) - a literature review.
Ozegowska KE; Pawelczyk LA
Ginekol Pol; 2015 Apr; 86(4):300-4. PubMed ID: 26117990
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
[TBL] [Abstract][Full Text] [Related]
13. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
[TBL] [Abstract][Full Text] [Related]
14. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
Popovska-Dimova Z; Krstevska B
Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance.
Lin L; Du T; Huang J; Huang LL; Yang DZ
Chin Med J (Engl); 2015 Jan; 128(2):169-74. PubMed ID: 25591557
[TBL] [Abstract][Full Text] [Related]
17. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome.
Shorakae S; Teede H; de Courten B; Lambert G; Boyle J; Moran LJ
Semin Reprod Med; 2015 Jul; 33(4):257-69. PubMed ID: 26132930
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome.
Nandi A; Chen Z; Patel R; Poretsky L
Endocrinol Metab Clin North Am; 2014 Mar; 43(1):123-47. PubMed ID: 24582095
[TBL] [Abstract][Full Text] [Related]
20. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
